Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SHJ002 Sterile Ophthalmic Solution for progressive myopia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHJ002 Sterile Ophthalmic Solution (SHJ002)

Snippet

Sponsor: Sunhawk Vision Biotech, Inc. | Conditions: Myopia, Progressive | Phase 2 | Status: ACTIVE_NOT_RECRUITING